Antigenic Variation of the Dengue Virus 2 Genotypes Impacts the Neutralization Activity of Human Antibodies in Vaccinees

Antigenic Variation of the Dengue Virus 2 Genotypes Impacts the Neutralization Activity of Human Antibodies in Vaccinees

Summary: Dengue virus (DENV) infects an estimated 390 million people each year worldwide. As tetravalent DENV vaccines have variable efficacy against DENV serotype 2 (DENV2), we evaluated the role of genetic diversity within the pre-membrane (prM) and envelope (E) proteins of DENV2 on vaccine perfor...

Full description

Bibliographic Details
Main Authors:	David R. Martinez, Boyd Yount, Usha Nivarthi, Jennifer E. Munt, Matthew J. Delacruz, Stephen S. Whitehead, Anna P. Durbin, Aravinda M. de Silva, Ralph S. Baric
Format:	Article
Language:	English
Published:	Elsevier 2020-10-01
Series:	Cell Reports
Subjects:	dengue virus 2 prM and E protein genetic variation genotype antibody neutralization vaccines
Online Access:	http://www.sciencedirect.com/science/article/pii/S2211124720312158

Similar Items

The Complexity of Antibody-Dependent Enhancement of Dengue Virus Infection
by: Maria G. Guzman, et al.
Published: (2010-12-01)

Natural immunogenic properties of bioinformatically predicted linear B-cell epitopes of dengue envelope and pre-membrane proteins
by: Mahesha N. Nadugala, et al.
Published: (2021-11-01)

Long-Term Protection Elicited by a DNA Vaccine Candidate Expressing the prM-E Antigen of Dengue Virus Serotype 3 in Mice
by: Kaihao Feng, et al.
Published: (2020-03-01)

Production of Proteins prM/M and E of Dengue Virus-3 in <i>Pichia pastoris</i>: Simplified Purification and Evaluation of Their Use as Antigens in Serological Diagnosis of Dengue
by: Michelle D. O. Teixeira, et al.
Published: (2020-09-01)

Dengue virus 4/2 envelope domain chimeric virus panel maps type-specific responses against dengue serotype 2
by: Deanna R. Zhu, et al.
Published: (2023-10-01)

Neutralizing Antibodies after Infection with Dengue 1 Virus
by: Gustavo Kourí, et al.
Published: (2007-02-01)

Anti-Idiotypic Antibodies Specific to prM Monoantibody Prevent Antibody Dependent Enhancement of Dengue Virus Infection
by: Miao Wang, et al.
Published: (2017-05-01)

A neutralizing-protective supersite of human monoclonal antibodies for yellow fever virus
by: Yan Li, et al.
Published: (2022-11-01)

Increased Cleavage of Japanese Encephalitis Virus prM Protein Promotes Viral Replication but Attenuates Virulence
by: Junyao Xiong, et al.
Published: (2022-06-01)

Role of Zika Virus prM Protein in Viral Pathogenicity and Use in Vaccine Development
by: Peter Nambala, et al.
Published: (2018-08-01)

DENV-3 precursor membrane (prM) glycoprotein enhances E protein immunogenicity and confers protection against DENV-2 infections in a murine model
by: Roberto S. Dias, et al.
Published: (2021-05-01)

Development and biochemical characteristics of a monoclonal antibody against prM protein of Tembusu virus
by: Siming Zhu, et al.
Published: (2023-12-01)

New Dengue Virus Type 1 Genotype in Colombo, Sri Lanka
by: Hasitha A. Tissera, et al.
Published: (2011-11-01)

Optimization of Flow-Cytometry Based Assay for Measuring Neutralizing Antibody Responses against Each of the Four Dengue Virus Serotypes
by: Pragati Sharma, et al.
Published: (2021-11-01)

Genotype-specific and cross-reactive neutralizing antibodies induced by dengue virus infection: detection of antibodies with different levels of neutralizing activities against homologous and heterologous genotypes of dengue virus type 2 in common marmosets (Callithrix jacchus)
by: Nor Azila Muhammad Azami, et al.
Published: (2018-03-01)

Analysis of Individuals from a Dengue-Endemic Region Helps Define the Footprint and Repertoire of Antibodies Targeting Dengue Virus 3 Type-Specific Epitopes
by: Daniela V. Andrade, et al.
Published: (2017-11-01)

The Human Antibody Response to Dengue Virus Infection
by: Aravinda M. de Silva, et al.
Published: (2011-11-01)

Human dengue virus serotype 2 neutralizing antibodies target two distinct quaternary epitopes.
by: Emily N Gallichotte, et al.
Published: (2018-02-01)

Cross-Protection Against Four Serotypes of Dengue Virus in Mice Conferred by a Zika DNA Vaccine
by: Ran Wang, et al.
Published: (2019-05-01)

Imported case of Dengue virus 3 genotype I in Rio de Janeiro state, Brazil
by: Marcos César Lima de Mendonça, et al.
Published: (2018-06-01)

New evidence of the development of dengue hemorrhagic fever during the dengue 3 epidemic in Cuba
by: Mayling Álvarez, et al.

Positive selection and evolution of dengue type-3 virus in the Indian subcontinent
by: Sukhmani K. Bedi, et al.
Published: (2013-08-01)

Epitope Addition and Ablation via Manipulation of a Dengue Virus Serotype 1 Infectious Clone
by: Emily N. Gallichotte, et al.
Published: (2017-02-01)

Genotype-Dependent Immunogenicity of Dengue Virus Type 2 Asian I and Asian/American Genotypes in Common Marmoset (<i>Callithrix jacchus)</i>: Discrepancy in Neutralizing and Infection-Enhancing Antibody Levels between Genotypes
by: Nor Azila Muhammad Azami, et al.
Published: (2021-10-01)

Neutralizing Antibody Response of Vaccinees to SARS-CoV-2 Variants
by: Gabriele Anichini, et al.
Published: (2021-05-01)

Protective Immune Responses Induced by an mRNA-LNP Vaccine Encoding prM-E Proteins against Japanese Encephalitis Virus Infection
by: Tao Chen, et al.
Published: (2022-05-01)

Role of pre-existing immunity in driving the dengue virus serotype 2 genotype shift in the Philippines: A retrospective analysis of serological data
by: Jean Claude Balingit, et al.
Published: (2024-02-01)

Role of Zika Virus Envelope Protein Domain III as a Target of Human Neutralizing Antibodies
by: Emily N. Gallichotte, et al.
Published: (2019-10-01)

The east coast districts are the possible epicenter of severe dengue in Sabah
by: Narinderjeet Kaur, et al.
Published: (2020-08-01)

Reporter Virus Neutralization Test Evaluation for Dengue and Zika Virus Diagnosis in Flavivirus Endemic Area
by: Jannyce G. C. Nunes, et al.
Published: (2021-07-01)

Blockade-of-Binding Activities toward Envelope-Associated, Type-Specific Epitopes as a Correlative Marker for Dengue Virus-Neutralizing Antibody
by: Poonsook Keelapang, et al.
Published: (2023-08-01)

Mutation in West Nile Virus Structural Protein prM during Human Infection
by: Yaniv Lustig, et al.
Published: (2016-09-01)

Complete protection for mice conferred by a DNA vaccine based on the Japanese encephalitis virus P3 strain used to prepare the inactivated vaccine in China
by: Xiaoyan Zheng, et al.
Published: (2020-08-01)

Pichia pastoris-expressed Dengue 3 Envelope-based Virus-like Particles Elicit Predominantly Domain III-Focused High Titer Neutralizing Antibodies
by: Lav eTripathi, et al.
Published: (2015-09-01)

Dengue Virus Type 3, South Pacific Islands, 2013
by: Van-Mai Cao-Lormeau, et al.
Published: (2014-06-01)

Neutralizing Antibody Response and Efficacy of Novel Recombinant Tetravalent Dengue DNA Vaccine Comprising Envelope Domain III in Mice
by: Ajit Kulkarni, et al.
Published: (2017-03-01)

Virus del dengue de serotipo 1 (DENV-1) de Colombia: su contribución a la presentación del dengue en el departamento de Santander
by: Raquel E. Ocazionez-Jiménez, et al.
Published: (2013-08-01)

Emergence of Dengue Virus Serotype 2 Cosmopolitan Genotype, Brazil
by: Marta Giovanetti, et al.
Published: (2022-08-01)

Dengue Mosaic Vaccines Enhance Cellular Immunity and Expand the Breadth of Neutralizing Antibody Against All Four Serotypes of Dengue Viruses in Mice
by: Jue Hou, et al.
Published: (2019-06-01)

Differential Expressions of Protamine 1 (PRM1) and Protamine 2 (PRM2) Genes as Markers of Semen Quality in Pasundan Bulls
by: Santoso, et al.
Published: (2022-11-01)